Viewing Study NCT06512467


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-05-27 @ 4:04 AM
Study NCT ID: NCT06512467
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-22
First Post: 2024-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module